Nigeria to pay N1bn to manufacturers of seized codeine

Archilin, one of the many varieties of cough syrup with Codeine. Bought from a drug bandit in Wuse Zone 4, Abuja at N2,000.
Archilin, one of the many varieties of cough syrup with Codeine. Bought from a drug bandit in Wuse Zone 4, Abuja at N2,000.

Moji Adeyeye, the Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), on Monday said the federal government would pay more than N1 billion as compensation to the companies that had their codeine impounded more than a year ago.

Mrs Adeyeye disclosed this on Monday in Lagos at a news conference to debunk a newspaper report that 70 per cent of medicines in Nigeria are fake.

Mrs Adeyeye said that there were about 2.5 million seizures of codeine made across the country, adding that government is working out compensations for the affected companies.

“It is about a year ago when the documentary about codeine was made which led to the Ministry of Health banning the product.

“Since that time, we have been having series of meeting with many government agencies and committees such as National Security Adviser group, the Presidency and the Ministry of Health.

“The final point is that we recalled about 2.5 million bottles of codeine and then put them on hold. This is sad because some companies did not commit the crime.

“So we put all the codeine on hold including the powder that they are using to the syrup. It will cost about N1 billion plus to reimburse these manufacturers,” she said.

Mrs Adeyeye said that government was already working on the reimbursement plan, adding that the agency is working round the clock to stem the manufacturing, distribution and use of substandard and fake drugs in the country.

“We are working on whatever the Ministry of Health is doing now to reimburse those companies affected. We just called a meeting about last two weeks on it.

“… they will be reimbursed because most of them legally produce the product in spite of the bad distribution channels.

“In tackling fake and substandard products, we do raids and many a time, our staffs don’t sleep, they keep vigil, mainly to intercept those drugs in concert with the Nigerian Customs Service.

“We are also working with the local manufacturers to make sure that their products attain the international standard,” she said.

On the fake news attributed to NAFDAC that 70 per cent of medicines in Nigeria are fake, Mrs Adeyeye said that the legal department of the agency would see to it.

She said that a study jointly carried out by NAFDAC, the World Health Organisation (WHO) and the Department for International Development (DFID) in 2005 revealed that fake medicines stood at 16 per cent.

She added that a survey conducted by NAFDAC in 2017 and 2018 on some widely used drugs showed that Nigerian medicines were 98 per cent wholesome.

She therefore described the report as “untrue and grossly inaccurate”.

(NAN)

Support PREMIUM TIMES' journalism of integrity and credibility

 

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


NEVER MISS A THING AGAIN! Subscribe to our newsletter

* indicates required

DOWNLOAD THE PREMIUM TIMES MOBILE APP

Now available on

  Premium Times Android mobile applicationPremium Times iOS mobile applicationPremium Times blackberry mobile applicationPremium Times windows mobile application

TEXT AD: This space is available for a Text_Ad.. Call Willie on +2347088095401 for more information


All rights reserved. This material and any other material on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from PREMIUM TIMES.